ACHC vs. EXAS

Last updated Jun 4, 2026

ACHC (Acadia Healthcare Company, Inc.) and EXAS (Exact Sciences Corporation) are both stocks. Both are in the Healthcare sector — ACHC in Medical Care Facilities, EXAS in Diagnostics & Research. At a 0.15 correlation, their price movements are largely independent.

Performance

ACHC vs. EXAS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ACHC

• 1D: 5.36%
• 1M: -7.06%
• YTD: 81.32%
• 6M: 75.15%
• 1Y: 14.66%
• 3Y*: -28.19%
• 5Y*: -17.07%
• 10Y*: -8.10%

EXAS

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ACHC vs. EXAS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ACHC Acadia Healthcare Company, Inc.	81.32%	-64.21%	-49.01%	-5.54%	35.62%	20.77%	51.29%	29.21%	-21.21%	-1.42%
EXAS Exact Sciences Corporation	3.30%	80.74%	-24.05%	49.42%	-36.39%	-41.26%	43.26%	46.56%	20.10%	293.26%

Correlation

The correlation between ACHC and EXAS is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.27
Correlation (All Time) Calculated using the full available price history since Feb 2, 2001	0.15

The correlation between ACHC and EXAS shifts across timeframes, from 0.05 (1 year) to 0.27 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ACHC : $2.34B EXAS : $19.91B
EPS ACHC : -$12.22 EXAS : -$1.10
PS Ratio ACHC : 0.69 EXAS : 6.12
PB Ratio ACHC : 1.19 EXAS : 8.29
Total Revenue (TTM) ACHC : $3.37B EXAS : $3.25B
Gross Profit (TTM) ACHC : $1.76B EXAS : $2.26B
EBITDA (TTM) ACHC : -$726.15M EXAS : $42.61M

Return for Risk

ACHC vs. EXAS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ACHC

ACHC Risk / Return Rank: 48
ACHC Sharpe Ratio Rank: 49
ACHC Sortino Ratio Rank: 50
ACHC Omega Ratio Rank: 49
ACHC Calmar Ratio Rank: 47
ACHC Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ACHC vs. EXAS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Acadia Healthcare Company, Inc. (ACHC) and Exact Sciences Corporation (EXAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ACHC	EXAS	Difference
Sharpe ratio Return per unit of total volatility	0.23	—	—
Sortino ratio Return per unit of downside risk	0.82	—	—
Omega ratio Gain probability vs. loss probability	1.10	—	—
Calmar ratio Return relative to maximum drawdown	0.26	—	—
Martin ratio Return relative to average drawdown	0.56	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	ACHC	EXAS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.23	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.37	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.17	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.00	—	—

Drawdowns

Drawdown Indicators

	ACHC	EXAS	Difference
Max Drawdown Largest peak-to-trough decline	-98.77%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-57.11%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-86.63%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-86.89%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-86.89%	—	—
Current Drawdown Current decline from peak	-71.11%	—	—
Average Drawdown Average peak-to-trough decline	-56.46%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	26.44%	—	—

Volatility

Volatility by Period

	ACHC	EXAS	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.34%	—	—
Volatility (6M) Calculated over the trailing 6-month period	49.97%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	65.21%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.82%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	48.63%	—	—

Dividends

ACHC vs. EXAS - Dividend Comparison

Neither ACHC nor EXAS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

ACHC vs. EXAS - Profitability Comparison

The chart below illustrates the profitability comparison between Acadia Healthcare Company, Inc. and Exact Sciences Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ACHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Acadia Healthcare Company, Inc. reported a gross profit of 0.00 and revenue of 828.80M. Therefore, the gross margin over that period was 0.0%.

EXAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exact Sciences Corporation reported a gross profit of 615.83M and revenue of 878.38M. Therefore, the gross margin over that period was 70.1%.

ACHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Acadia Healthcare Company, Inc. reported an operating income of 0.00 and revenue of 828.80M, resulting in an operating margin of 0.0%.

EXAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exact Sciences Corporation reported an operating income of -76.68M and revenue of 878.38M, resulting in an operating margin of -8.7%.

ACHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Acadia Healthcare Company, Inc. reported a net income of 4.11M and revenue of 828.80M, resulting in a net margin of 0.5%.

EXAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exact Sciences Corporation reported a net income of -85.96M and revenue of 878.38M, resulting in a net margin of -9.8%.

Frequently Asked Questions

Can I hold both ACHC and EXAS in my portfolio?

ACHC and EXAS have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.